Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Hair loss requires customized treatments based on its various causes and types.

Alopecia areata causes patchy hair loss and has no cure, but treatments like corticosteroids and minoxidil can help.

Children's hair loss can have various causes, including infections, autoimmune issues, physical stress, nutritional problems, and genetic factors.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

The article discusses various treatments for different types of non-scarring hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Skin changes can help predict thyroid diseases.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Mice with autoimmune hair loss showed signs of heart problems.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.